Tuberc Respir Dis.  2003 May;54(5):532-541. 10.4046/trd.2003.54.5.532.

Effect of Doxycycline on the Acute Lung Injury Induced by Gut Ischemia/Reperfusion

Affiliations
  • 1Department of Physiology, Catholic University of Daegu, Daegu, Korea.
  • 2Department of Internal Medicine, Catholic University of Daegu, Daegu, Korea. sclee@cataegu.ac.kr

Abstract

BACKGROUND: Phospholipase A2 (PLA2) has been known to be involved in the pathogenesis of acute lung injury (ALI) including ARDS. Since doxycycline has the property of inhibiting secretory group II PLA2, the therapeutic effect of doxycycline hyclate was investigated for gut ischemia/reperfusion (I/R)-induced ALI in Sprague-Dawley rats.
METHODS
ALI was induced in Sprague-Dawley rats by clamping of the superior mesenteric artery for 60 min, followed by 120 min of reperfusion. To confirm the pathogenetic mechanisms of this ALI associated with neutrophilic oxidative stress, we measured bronchoalveolar lavage (BAL) protein content and lung MPO, and performed cyto chemical electron microscopy for detection of free radicals, assay of PLA2 activity and cytochrome-c reduction assay.
RESULTS
In gut I/R-induced ALI rats, protein leakage, pulmonary neutrophil accumulation, free radical production and lung PLA2 activity were all increased. These effects were reversed by doxycycline hyclate.
CONCLUSION
Doxycycline appars to be effective in ameliorating the gut I/R-induced ALI by inhibiting PLA2, thereby decreasing the production of free radicals from neutrophils.

Keyword

ALI; Neutrophils; Oxidative stress; Doxycyclin

MeSH Terms

Acute Lung Injury*
Animals
Bronchoalveolar Lavage
Constriction
Doxycycline*
Free Radicals
Lung
Mesenteric Artery, Superior
Microscopy, Electron
Neutrophils
Oxidative Stress
Phospholipases A2
Rats
Rats, Sprague-Dawley
Reperfusion
Doxycycline
Free Radicals
Phospholipases A2
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr